Form 8-K - Current report:
SEC Accession No. 0001558370-23-005917
Filing Date
2023-04-14
Accepted
2023-04-14 07:11:39
Documents
42
Period of Report
2023-04-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20230414x8k.htm   iXBRL 8-K 39427
2 EX-99.1 acrs-20230414xex99d1.htm EX-99.1 48101
3 GRAPHIC acrs-20230414xex99d1g001.jpg GRAPHIC 162889
4 GRAPHIC acrs-20230414xex99d1g002.jpg GRAPHIC 340401
5 GRAPHIC acrs-20230414xex99d1g003.jpg GRAPHIC 164964
6 GRAPHIC acrs-20230414xex99d1g004.jpg GRAPHIC 206868
7 GRAPHIC acrs-20230414xex99d1g005.jpg GRAPHIC 177913
8 GRAPHIC acrs-20230414xex99d1g006.jpg GRAPHIC 161684
9 GRAPHIC acrs-20230414xex99d1g007.jpg GRAPHIC 77132
10 GRAPHIC acrs-20230414xex99d1g008.jpg GRAPHIC 153938
11 GRAPHIC acrs-20230414xex99d1g009.jpg GRAPHIC 152696
12 GRAPHIC acrs-20230414xex99d1g010.jpg GRAPHIC 179352
13 GRAPHIC acrs-20230414xex99d1g011.jpg GRAPHIC 137451
14 GRAPHIC acrs-20230414xex99d1g012.jpg GRAPHIC 145016
15 GRAPHIC acrs-20230414xex99d1g013.jpg GRAPHIC 169025
16 GRAPHIC acrs-20230414xex99d1g014.jpg GRAPHIC 249098
17 GRAPHIC acrs-20230414xex99d1g015.jpg GRAPHIC 79796
18 GRAPHIC acrs-20230414xex99d1g016.jpg GRAPHIC 207706
19 GRAPHIC acrs-20230414xex99d1g017.jpg GRAPHIC 153058
20 GRAPHIC acrs-20230414xex99d1g018.jpg GRAPHIC 134007
21 GRAPHIC acrs-20230414xex99d1g019.jpg GRAPHIC 148240
22 GRAPHIC acrs-20230414xex99d1g020.jpg GRAPHIC 77899
23 GRAPHIC acrs-20230414xex99d1g021.jpg GRAPHIC 165309
24 GRAPHIC acrs-20230414xex99d1g022.jpg GRAPHIC 179625
25 GRAPHIC acrs-20230414xex99d1g023.jpg GRAPHIC 161524
26 GRAPHIC acrs-20230414xex99d1g024.jpg GRAPHIC 65954
27 GRAPHIC acrs-20230414xex99d1g025.jpg GRAPHIC 146759
28 GRAPHIC acrs-20230414xex99d1g026.jpg GRAPHIC 187237
29 GRAPHIC acrs-20230414xex99d1g027.jpg GRAPHIC 164432
30 GRAPHIC acrs-20230414xex99d1g028.jpg GRAPHIC 76130
  Complete submission text file 0001558370-23-005917.txt   6409394

Data Files

Seq Description Document Type Size
31 EX-101.SCH acrs-20230414.xsd EX-101.SCH 3253
32 EX-101.LAB acrs-20230414_lab.xml EX-101.LAB 632
33 EX-101.PRE acrs-20230414_pre.xml EX-101.PRE 10569
36 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20230414x8k_htm.xml XML 4840
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 23819711
SIC: 2834 Pharmaceutical Preparations